Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioanna Stamati

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Discovery|March 24, 2015
Emerging formats for next-generation antibody drug conjugatesMahendra P Deonarain, Gokhan Yahioglu, Ioanna Stamati, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|June 10, 2010
Novel photosensitisers derived from pyropheophorbide-a: uptake by cells and photodynamic efficiency in vitroIoanna Stamati, Marina K Kuimova, Mattia Lion, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 3, 2022
Clinical application of extended half-life factor VIII in children with severe haemophilia AAthina Dettoraki, Aikaterini Michalopoulou, Michalis Mazarakis, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|August 28, 2007
Fluorescence characterisation of multiply-loaded anti-HER2 single chain Fv-photosensitizer conjugates suitable for photodynamic therapyMarina K Kuimova, Manpreet Bhatti, Mahendra Deonarain, et al.
Life (Basel, Switzerland)|September 27, 2025
Real-World Use of Extended Half-Life Factor IX in Children with Haemophilia BAthina Dettoraki, Aikaterini Michalopoulou, Stefanos Saslis, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
Small-Format Drug Conjugates: A Viable Alternative to ADCs for Solid Tumours?Mahendra P Deonarain, Gokhan Yahioglu, Ioanna Stamati, et al.
Plos One|August 28, 2015
Development of Photodynamic Antimicrobial Chemotherapy (PACT) for Clostridium difficileLuisa De Sordi, M Adil Butt, Hayley Pye, et al.
Molecular Cancer Therapeutics|June 10, 2025
Anti-HER2, high-DAR Antibody Fragment Drug Conjugates (FDC) with a Glucuronide-based MMAE linker-payload demonstrates superior efficacy over IgG-based ADCsIoanna Stamati, Gokhan Yahioglu, Soraya Diez-Posada, et al.
Oncotarget|May 26, 2018
Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expressionHayley Pye, Mohammed Adil Butt, Laura Funnell, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Discovery|March 24, 2015
Emerging formats for next-generation antibody drug conjugatesMahendra P Deonarain, Gokhan Yahioglu, Ioanna Stamati, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|June 10, 2010
Novel photosensitisers derived from pyropheophorbide-a: uptake by cells and photodynamic efficiency in vitroIoanna Stamati, Marina K Kuimova, Mattia Lion, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 3, 2022
Clinical application of extended half-life factor VIII in children with severe haemophilia AAthina Dettoraki, Aikaterini Michalopoulou, Michalis Mazarakis, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|August 28, 2007
Fluorescence characterisation of multiply-loaded anti-HER2 single chain Fv-photosensitizer conjugates suitable for photodynamic therapyMarina K Kuimova, Manpreet Bhatti, Mahendra Deonarain, et al.
Life (Basel, Switzerland)|September 27, 2025
Real-World Use of Extended Half-Life Factor IX in Children with Haemophilia BAthina Dettoraki, Aikaterini Michalopoulou, Stefanos Saslis, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
Small-Format Drug Conjugates: A Viable Alternative to ADCs for Solid Tumours?Mahendra P Deonarain, Gokhan Yahioglu, Ioanna Stamati, et al.
Plos One|August 28, 2015
Development of Photodynamic Antimicrobial Chemotherapy (PACT) for Clostridium difficileLuisa De Sordi, M Adil Butt, Hayley Pye, et al.
Molecular Cancer Therapeutics|June 10, 2025
Anti-HER2, high-DAR Antibody Fragment Drug Conjugates (FDC) with a Glucuronide-based MMAE linker-payload demonstrates superior efficacy over IgG-based ADCsIoanna Stamati, Gokhan Yahioglu, Soraya Diez-Posada, et al.
Oncotarget|May 26, 2018
Using antibody directed phototherapy to target oesophageal adenocarcinoma with heterogeneous HER2 expressionHayley Pye, Mohammed Adil Butt, Laura Funnell, et al.
Pageof 1